Full Text
PCV46 SWITCHING PATIENTS TO ROSUVASTATIN FROM ATORVASTATIN OR OTHER STATINS IS COST-EFFECTIVE- PHARMACOECONOMIC ANALYSIS OF MERCURY I

Abstract

Authors

M James J Brown H Schuster

Back to Volume 6, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×